Canada markets closed

Armata Pharmaceuticals, Inc. (ARMP)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
3.0912-0.1688 (-5.18%)
At close: 03:59PM EDT
3.1500 +0.06 (+1.90%)
After hours: 05:26PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 111.76M
Enterprise Value 218.61M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.06
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.47

Trading Information

Stock Price History

Beta (5Y Monthly) 0.70
52-Week Change 3127.21%
S&P500 52-Week Change 326.27%
52 Week High 35.2600
52 Week Low 31.0700
50-Day Moving Average 33.2906
200-Day Moving Average 33.0294

Share Statistics

Avg Vol (3 month) 316.13k
Avg Vol (10 day) 315.46k
Shares Outstanding 536.15M
Implied Shares Outstanding 638.13M
Float 810.72M
% Held by Insiders 170.33%
% Held by Institutions 13.87%
Shares Short (Apr 15, 2024) 49.89k
Short Ratio (Apr 15, 2024) 40.58
Short % of Float (Apr 15, 2024) 40.09%
Short % of Shares Outstanding (Apr 15, 2024) 40.03%
Shares Short (prior month Mar 15, 2024) 413.32k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 10, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:14
Last Split Date 3May 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-626.90%

Management Effectiveness

Return on Assets (ttm)-26.32%
Return on Equity (ttm)-3,439.35%

Income Statement

Revenue (ttm)4.53M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)45.40%
Gross Profit (ttm)N/A
EBITDA -39.92M
Net Income Avi to Common (ttm)-69.05M
Diluted EPS (ttm)-1.9100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.52M
Total Cash Per Share (mrq)0.37
Total Debt (mrq)120.37M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.16
Book Value Per Share (mrq)-0.89

Cash Flow Statement

Operating Cash Flow (ttm)-47.42M
Levered Free Cash Flow (ttm)-27.75M